Construction and characterization of RNase-based targeted therapeutics.
Newton
Dianne L
DL
SAIC-Frederick, National Cancer Institute, Frederick, MD, USA.
Futami
Junichiro
J
Ruby
Dale
D
Rybak
Susanna M
SM
D017931:DNA Primers / Q000737:chemistry; D015870:Gene Expression; D005818:Genetic Engineering / Q000379:methods; D006801:Humans; D007135:Immunoglobulin Variable Region / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D016296:Mutagenesis; D016133:Polymerase Chain Reaction / Q000379:methods*; D011990:Receptors, Transferrin / Q000235:genetics / Q000276:immunology* / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification* / Q000627:therapeutic use; D012259:Ribonuclease, Pancreatic / Q000737:chemistry / Q000235:genetics / Q000302:isolation & purification / Q000627:therapeutic use*
D017931:DNA Primers; D007135:Immunoglobulin Variable Region; D011990:Receptors, Transferrin; D011993:Recombinant Fusion Proteins; D012259:Ribonuclease, Pancreatic